Exact Mass: 426.0919232
Exact Mass Matches: 426.0919232
Found 95 metabolites which its exact mass value is equals to given mass value 426.0919232,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cysteineglutathione disulfide
Cysteineglutathione disulfide is a molecule that is formed upon oxidative stress of glutathione, that will form mixed disulfides with protein thiol groups, causing reversible S-glutathionylation. S-glutathionylation is an important post-translational modification responsible for transducing oxidant signals. S-glutathionylation of thiols confers protection against their irreversible oxidation, like for instance the formation of sulphonic acid moieties. If the targeted cysteine is a functionally critical amino acid, S-glutathionylation will however also modify protein function. (PMID 16515838). S-sulfonation and S-thiolation of transthyretin Phe33Cys has been detected in a patient with familial transthyretin amyloidosis. (PMID 12876326). In Cystinotic human skin fibroblasts in tissue culture there is an accumulation of cystine. Stored cystine in cystinotic tissues may derive in part from glutathione-cysteine mixed disulfide via transpeptidation. (PMID 6130452). Cystinosis is an autosomal recessive disorder caused by an impaired transport of cystine out of lysosomes. (PMID 15042893). Cysteineglutathione disulfide is a molecule that is formed upon oxidative stress of glutathione, that will form mixed disulfides with protein thiol groups, causing reversible S-glutathionylation. [HMDB]
(-)-Epiafzelechin 3-gallate
(-)-Epiafzelechin 3-gallate is found in tea. (-)-Epiafzelechin 3-gallate is isolated from Camellia sinensis var. assamica (oolong tea). Isolated from Camellia sinensis variety assamica (oolong tea). (-)-Epiafzelechin 3-gallate is found in tea.
(3-(2-(4-(2-(Trifluoromethyl)phenoxy)piperidin-1-yl)thiazol-5-yl)-1,2,4-oxadiazol-5-yl)methanol
Cysteine-glutathione disulfide
Fevipiprant
C19H17F3N2O4S (426.08610780000004)
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent C177182 - Prostaglandin Receptor Antagonist
8-Deoxy-15-(3-hydroxy-2-methyl-propanoyl)-lactucin-3-sulfate
(-)-sanguinolignan D|(8R,7S,8S)-7-acetoxy-3,3,4,4-bis(methylenedioxy)-7-oxolignano-9,9-lactone
5,7-Diacetoxy-3-(4-acetoxy-phenyl)-6-methoxy-chromen-4-on|5,7-diacetoxy-3-(4-acetoxy-phenyl)-6-methoxy-chromen-4-one
8-Me ehter,tri-Ac-1,3,5,8-Tetrahydroxy-2-methylanthraquinone
3,4,5-trimetoxyphenil 1-O-beta-(6-sulpho)-glucopyranoside
C15H22O12S (426.08319320000004)
3-Carboxy-6,7-dihydroxy-1-(3,4-dihydroxyphenyl)-naphthalene-9,2-O-malic acid ester
Cys Cys Asp Ser
Cys Cys Ser Asp
Cys Asp Cys Ser
Cys Asp Ser Cys
Cys Ser Cys Asp
Cys Ser Asp Cys
Asp Cys Cys Ser
Asp Cys Ser Cys
Asp Ser Cys Cys
Ser Cys Cys Asp
Ser Cys Asp Cys
Ser Asp Cys Cys
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
.beta.-D-Glucopyranosiduronic acid, phenyl 1-thio-, methyl ester, triacetate
2-amino-4-(3-chlorophenyl)-6-(2-furanylmethyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester
C22H19ClN2O5 (426.09824340000006)
(4AR,6R,7S,8R,8AR)-8-((5R,6R)-3-Carboxy-tetrahydro-4,5,6-trihydroxy-2H-pyran-2-yloxy)-hexahydro-6,7-dihydroxy-2-methylpyrano[3,2-D][1,3]dioxine-2-carboxylic acid)
Fevipiprant
C19H17F3N2O4S (426.08610780000004)
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent C177182 - Prostaglandin Receptor Antagonist
methyl (2R)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
(2S)-2-[(2R,3R,4R,5S,6R)-3-[[(2R)-2-amino-3-formylsulfanylpropanoyl]amino]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanedioic acid
C14H22N2O11S (426.09442620000004)
(-)-sanguinolignan D
A lignan isolated from the leaves of Piper sanguineispicum.
3-(2-chlorophenyl)-6-[3-(cyclopropylmethoxy)-4-methoxyphenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
C21H19ClN4O2S (426.09171840000005)
2-[(5-amino-1-phenacyl-1,2,4-triazol-3-yl)thio]-N-(3-cyano-4,5-dimethyl-2-thiophenyl)acetamide
2-Chloro-N-[(E)-(2-morpholin-4-yl-4-phenyl-1,3-thiazol-5-yl)methylideneamino]benzamide
C21H19ClN4O2S (426.09171840000005)
epiafzelechin 3-gallate
A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epiafzelechin.
L-cysteine glutathione disulfide
An organic disulfide that is the L-cysteinyl derivative of glutathione.
Keto Ziprasidone
C21H19ClN4O2S (426.09171840000005)
Keto Ziprasidone is an impurity of Ziprasidone[1]. Ziprasidone, an antipsychotic agent, is a combined 5-HT (serotonin) and dopamine receptor antagonist[2].
methyl (1r,2r)-2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
6,6-dichloro-3-methoxy-n,5-dimethyl-n-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(3,4,5-trimethoxyphenoxy)oxan-2-yl]methoxysulfonic acid
C15H22O12S (426.08319320000004)
5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
4',5',7-triacetoxy-2'-methoxyisoflavone
{"Ingredient_id": "HBIN009982","Ingredient_name": "4',5',7-triacetoxy-2'-methoxyisoflavone","Alias": "NA","Ingredient_formula": "C22H18O9","Ingredient_Smile": "CC(=O)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC(=C(C=C3OC)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21512","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,15,18-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12-trione
(2s)-3-{[(3as,9bs)-6-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-9-yl]methoxy}-2-methyl-3-oxopropoxysulfonic acid
(5ar,11ar)-8,9-bis(acetyloxy)-12-oxo-10,11a-dihydro-5ah-5,11-dioxatetraphen-3-yl acetate
2-(acetyloxy)-4-[7-(acetyloxy)-4-oxochromen-3-yl]-5-methoxyphenyl acetate
2-(acetyloxy)-4-(3,4-dihydroxyphenyl)-4',5,6-trihydroxy-[1,1'-biphenyl]-3-yl acetate
5-(carboxymethyl)-8-(2,6-dihydroxybenzoyl)-4-oxo-2-propylchromene-7-carboxylic acid
(2s)-3-{[(3as,9as,9bs)-6-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-9-yl]methoxy}-2-methyl-3-oxopropoxysulfonic acid
(2e,5s)-6,6-dichloro-3-methoxy-n,5-dimethyl-n-[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
2h-1,3-benzodioxol-5-yl[4-(2h-1,3-benzodioxole-5-carbonyl)-2-oxooxolan-3-yl]methyl acetate
(11s)-4-carboxy-4,17,19-trihydroxy-11-methyl-2,13-dioxo-12-oxa-6-thiatricyclo[13.4.0.0³,⁷]nonadeca-1(19),15,17-trien-6-ium-6-olate
methyl 2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
8,9-bis(acetyloxy)-12-oxo-10,11a-dihydro-5ah-5,11-dioxatetraphen-3-yl acetate
(1r,4r,5s,9s,11r,14s,15s,18s,19s)-5,15,18-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12-trione
2-[4-(3,4-dihydroxyphenyl)-7-hydroxy-6-methylnaphthalene-2-carbonyloxy]butanedioic acid
(2e,5s)-6,6-dichloro-3-methoxy-n,5-dimethyl-n-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
5-(acetyloxy)-3-[4-(acetyloxy)phenyl]-6-methoxy-4-oxochromen-7-yl acetate
5-(2-chloro-1-hydroxyethyl)-4a-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
[3,4,5-trihydroxy-6-(3,4,5-trimethoxyphenoxy)oxan-2-yl]methoxysulfonic acid
C15H22O12S (426.08319320000004)